Core Insights - Stadium Capital Management has initiated a new position in Insperity, acquiring 263,715 shares valued at approximately $13 million, making it one of the fund's largest holdings [1][2][6] - Insperity's stock has significantly underperformed, down 55% over the past year, while the S&P 500 has increased by 14% during the same period [3][8] Company Overview - Insperity provides human resources outsourcing, payroll administration, employee benefits, compliance, and cloud-based HR management solutions, primarily targeting small and mid-sized businesses in the U.S. [5] - The company reported a trailing twelve months (TTM) revenue of $6.8 billion and a net income of $17 million, with a dividend yield of 7% [4] Financial Performance - In the last quarter, Insperity's revenue rose by 4% to $1.6 billion, but the company faced a net loss of $20 million due to elevated healthcare costs, with adjusted EBITDA falling to $10 million [7][8] - Management has indicated progress on cost controls and the benefits of a new multi-year contract with UnitedHealthcare, which is expected to reduce large-claim cost exposure starting in 2026 [6][8] Investment Perspective - The significant investment by Stadium Capital suggests confidence in Insperity's potential for operational recovery rather than a structural decline, despite current challenges [6][8] - The current stock price reflects pessimism about future conditions, presenting a potential opportunity for investors who believe in the company's long-term recurring-revenue model [8]